Publications 2015
Tourneau, C.L et al.
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
Lancet Oncol.
doi: 10.1016/S1470-2045(15)00188-6
Bork P. et al.
Tara Oceans studies plankton at PLANETARY SCALE
Science.2015 348(6237):873-873.
doi: 10.1126/science.aac5605
Eleveld, T.F. et al.
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
Nature Genetics.
doi: 10.1038/ng.3333
Ravens S. et al.
Tip60 complex binds to active Pol II promoters and a subset of enhancers and co-regulates the c-Myc network in mouse embryonic stem cells
Epigenetics Chromatin. 2015 Nov 6;8:45.
doi: 10.1186/s13072-015-0039-z
Brahimi-Horn MC. et al.
Knockout of Vdac1activates hypoxia-inducible factor through reactive oxygen species generation andinduces tumor growth by promoting metabolic reprogramming and inflammation
Cancer Metab. 2015 Aug 26;3:8
doi:
Madoui MA. et al.
Genome assembly using Nanopore-guided long and error-free DNA reads
Bmc Genomics,. 2015, 16:327.
doi: 10.1186/s12864-015-1519-z
Seubert B. et al.
Tetraspanin CD63 acts as a pro-metastaticfactor via ?-catenin stabilization
Int J Cancer. 2015 May 15;136(10):2304-15
doi: 10.1002/ijc.29296